List of Tables
Table 1. Global Interleukin-17 Inhibitors Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Interleukin-17 Inhibitors Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Interleukin-17 Inhibitors Market Competitive Situation by Manufacturers in 2025
Table 4. Global Interleukin-17 Inhibitors Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Interleukin-17 Inhibitors Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Interleukin-17 Inhibitors Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Interleukin-17 Inhibitors Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Interleukin-17 Inhibitors Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Interleukin-17 Inhibitors, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Interleukin-17 Inhibitors, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Interleukin-17 Inhibitors, Product Types and Applications
Table 12. Global Key Manufacturers of Interleukin-17 Inhibitors, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Interleukin-17 Inhibitors Companies by Tier (Tier 1, Tier 2, Tier 3), based on Interleukin-17 Inhibitors Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Interleukin-17 Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Interleukin-17 Inhibitors Sales by Region (K Units), 2021–2026
Table 18. Global Interleukin-17 Inhibitors Sales Market Share by Region (2021–2026)
Table 19. Global Interleukin-17 Inhibitors Sales by Region (K Units), 2027–2032
Table 20. Global Interleukin-17 Inhibitors Sales Market Share by Region (2027–2032)
Table 21. Global Interleukin-17 Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 22. Global Interleukin-17 Inhibitors Revenue Market Share by Region (2021–2026)
Table 23. Global Interleukin-17 Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 24. Global Interleukin-17 Inhibitors Revenue Market Share by Region (2027–2032)
Table 25. North America Interleukin-17 Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Interleukin-17 Inhibitors Sales by Country (K Units), 2021–2026
Table 27. North America Interleukin-17 Inhibitors Sales by Country (K Units), 2027–2032
Table 28. North America Interleukin-17 Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 29. North America Interleukin-17 Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Interleukin-17 Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Interleukin-17 Inhibitors Sales by Country (K Units), 2021–2026
Table 32. Europe Interleukin-17 Inhibitors Sales by Country (K Units), 2027–2032
Table 33. Europe Interleukin-17 Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Interleukin-17 Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Interleukin-17 Inhibitors Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Interleukin-17 Inhibitors Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Interleukin-17 Inhibitors Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Interleukin-17 Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Interleukin-17 Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Interleukin-17 Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Interleukin-17 Inhibitors Sales by Country (K Units), 2021–2026
Table 42. Latin America Interleukin-17 Inhibitors Sales by Country (K Units), 2027–2032
Table 43. Latin America Interleukin-17 Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Interleukin-17 Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Interleukin-17 Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Interleukin-17 Inhibitors Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Interleukin-17 Inhibitors Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Interleukin-17 Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Interleukin-17 Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 50. Global Interleukin-17 Inhibitors Sales (K Units) by Type (2021–2026)
Table 51. Global Interleukin-17 Inhibitors Sales (K Units) by Type (2027–2032)
Table 52. Global Interleukin-17 Inhibitors Sales Market Share by Type (2021–2026)
Table 53. Global Interleukin-17 Inhibitors Sales Market Share by Type (2027–2032)
Table 54. Global Interleukin-17 Inhibitors Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Interleukin-17 Inhibitors Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Interleukin-17 Inhibitors Revenue Market Share by Type (2021–2026)
Table 57. Global Interleukin-17 Inhibitors Revenue Market Share by Type (2027–2032)
Table 58. Global Interleukin-17 Inhibitors Price (US$/Unit) by Type (2021–2026)
Table 59. Global Interleukin-17 Inhibitors Price (US$/Unit) by Type (2027–2032)
Table 60. Global Interleukin-17 Inhibitors Sales (K Units) by Application (2021–2026)
Table 61. Global Interleukin-17 Inhibitors Sales (K Units) by Application (2027–2032)
Table 62. Global Interleukin-17 Inhibitors Sales Market Share by Application (2021–2026)
Table 63. Global Interleukin-17 Inhibitors Sales Market Share by Application (2027–2032)
Table 64. Global Interleukin-17 Inhibitors Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Interleukin-17 Inhibitors Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Interleukin-17 Inhibitors Revenue Market Share by Application (2021–2026)
Table 67. Global Interleukin-17 Inhibitors Revenue Market Share by Application (2027–2032)
Table 68. Global Interleukin-17 Inhibitors Price (US$/Unit) by Application (2021–2026)
Table 69. Global Interleukin-17 Inhibitors Price (US$/Unit) by Application (2027–2032)
Table 70. Chongqing Genrix Biopharmaceutical Company Information
Table 71. Chongqing Genrix Biopharmaceutical Description and Business Overview
Table 72. Chongqing Genrix Biopharmaceutical Interleukin-17 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Chongqing Genrix Biopharmaceutical Interleukin-17 Inhibitors Product
Table 74. Chongqing Genrix Biopharmaceutical Recent Developments/Updates
Table 75. Jiangsu Hengrui Medicine Company Information
Table 76. Jiangsu Hengrui Medicine Description and Business Overview
Table 77. Jiangsu Hengrui Medicine Interleukin-17 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Jiangsu Hengrui Medicine Interleukin-17 Inhibitors Product
Table 79. Jiangsu Hengrui Medicine Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Interleukin-17 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Novartis Interleukin-17 Inhibitors Product
Table 84. Novartis Recent Developments/Updates
Table 85. UCB Company Information
Table 86. UCB Description and Business Overview
Table 87. UCB Interleukin-17 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. UCB Interleukin-17 Inhibitors Product
Table 89. UCB Recent Developments/Updates
Table 90. Eli Lilly and Co. Company Information
Table 91. Eli Lilly and Co. Description and Business Overview
Table 92. Eli Lilly and Co. Interleukin-17 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Eli Lilly and Co. Interleukin-17 Inhibitors Product
Table 94. Eli Lilly and Co. Recent Developments/Updates
Table 95. Akesobio Company Information
Table 96. Akesobio Description and Business Overview
Table 97. Akesobio Interleukin-17 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Akesobio Interleukin-17 Inhibitors Product
Table 99. Akesobio Recent Developments/Updates
Table 100. AstraZeneca Company Information
Table 101. AstraZeneca Description and Business Overview
Table 102. AstraZeneca Interleukin-17 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. AstraZeneca Interleukin-17 Inhibitors Product
Table 104. AstraZeneca Recent Developments/Updates
Table 105. DICE Therapeutics Company Information
Table 106. DICE Therapeutics Description and Business Overview
Table 107. DICE Therapeutics Interleukin-17 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. DICE Therapeutics Interleukin-17 Inhibitors Product
Table 109. DICE Therapeutics Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Interleukin-17 Inhibitors Distributors List
Table 113. Interleukin-17 Inhibitors Customers List
Table 114. Interleukin-17 Inhibitors Market Trends
Table 115. Interleukin-17 Inhibitors Market Drivers
Table 116. Interleukin-17 Inhibitors Market Challenges
Table 117. Interleukin-17 Inhibitors Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Product Picture of Interleukin-17 Inhibitors
Figure 2. Global Interleukin-17 Inhibitors Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Interleukin-17 Inhibitors Market Share by Type: 2025 & 2032
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. Global Interleukin-17 Inhibitors Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Interleukin-17 Inhibitors Market Share by Application: 2025 & 2032
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Interleukin-17 Inhibitors Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Interleukin-17 Inhibitors Market Size (US$ Million), 2021–2032
Figure 13. Global Interleukin-17 Inhibitors Sales (K Units), 2021–2032
Figure 14. Global Interleukin-17 Inhibitors Average Price (US$/Unit), 2021–2032
Figure 15. Interleukin-17 Inhibitors Report Years Considered
Figure 16. Interleukin-17 Inhibitors Sales Share by Manufacturers in 2025
Figure 17. Global Interleukin-17 Inhibitors Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Interleukin-17 Inhibitors Players: Market Share by Revenue in Interleukin-17 Inhibitors in 2025
Figure 19. Interleukin-17 Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Interleukin-17 Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Interleukin-17 Inhibitors Sales Market Share by Country (2021–2032)
Figure 22. North America Interleukin-17 Inhibitors Revenue Market Share by Country (2021–2032)
Figure 23. United States Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Interleukin-17 Inhibitors Sales Market Share by Country (2021–2032)
Figure 26. Europe Interleukin-17 Inhibitors Revenue Market Share by Country (2021–2032)
Figure 27. Germany Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Interleukin-17 Inhibitors Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Interleukin-17 Inhibitors Revenue Market Share by Region (2021–2032)
Figure 34. China Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. China Taiwan Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Southeast Asia Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Latin America Interleukin-17 Inhibitors Sales Market Share by Country (2021–2032)
Figure 42. Latin America Interleukin-17 Inhibitors Revenue Market Share by Country (2021–2032)
Figure 43. Mexico Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Brazil Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Argentina Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Colombia Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Middle East and Africa Interleukin-17 Inhibitors Sales Market Share by Country (2021–2032)
Figure 48. Middle East and Africa Interleukin-17 Inhibitors Revenue Market Share by Country (2021–2032)
Figure 49. Turkey Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Saudi Arabia Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. UAE Interleukin-17 Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Global Sales Market Share of Interleukin-17 Inhibitors by Type (2021–2032)
Figure 53. Global Revenue Market Share of Interleukin-17 Inhibitors by Type (2021–2032)
Figure 54. Global Interleukin-17 Inhibitors Price (US$/Unit) by Type (2021–2032)
Figure 55. Global Sales Market Share of Interleukin-17 Inhibitors by Application (2021–2032)
Figure 56. Global Revenue Market Share of Interleukin-17 Inhibitors by Application (2021–2032)
Figure 57. Global Interleukin-17 Inhibitors Price (US$/Unit) by Application (2021–2032)
Figure 58. Interleukin-17 Inhibitors Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
